| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 147, 238-244, Copyright © 1995 by American Society for Investigative Pathology
REGULAR ARTICLES |
T Wisniewski, AA Golabek, E Kida, KE Wisniewski and B Frangione
Department of Pathology, New York University Medical Center, New York 10016, USA.
Several apolipoproteins are known to be closely associated with amyloid fibrillogenesis. Serum amyloid A, apolipoprotein (apo) AII and apo A1 are each deposited as biochemically distinct forms of amyloid. Late- onset Alzheimer's disease is linked to one isotype of apo E, apo E4. Apo E and apo E4 in particular have been shown to modulate amyloid fibril formation by amyloid-beta peptides in vitro. Furthermore, the carboxy terminus of apo E has been shown to be a constituent of plaque amyloid. We show immunohistochemically and electron microscopically the presence of apo A1 in senile plaques. The intact apo A1 can itself form amyloid-like fibrils in vitro that are Congo Red positive. We propose that some proteins when misfolded can propagate this misfolding to identical units, either autocatalytically or to other proteins that are induced to fold into the same abnormal conformation. This conformational mimicry may initiate and/or augment fibrillogenesis in Alzheimer's disease.
This article has been cited by other articles:
![]() |
K. Abildayeva, J. F. P. Berbee, A. Blokland, P. J. Jansen, F. J. Hoek, O. Meijer, D. Lutjohann, T. Gautier, T. Pillot, J. De Vente, et al. Human apolipoprotein C-I expression in mice impairs learning and memory functions J. Lipid Res., April 1, 2008; 49(4): 856 - 869. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Liz, C. M. Gomes, M. J. Saraiva, and M. M. Sousa ApoA-I cleaved by transthyretin has reduced ability to promote cholesterol efflux and increased amyloidogenicity J. Lipid Res., November 1, 2007; 48(11): 2385 - 2395. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Scarmeas Invited Commentary: Lipoproteins and Dementia--Is It the Apolipoprotein A-I? Am. J. Epidemiol., May 1, 2007; 165(9): 993 - 997. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sakata, Y. Hoshii, T. Nakamura, M. Kiyama, H. Arai, M. Omoto, M. Morimatsu, and T. Ishihara Colocalization of Apolipoprotein AI in Various Kinds of Systemic Amyloidosis J. Histochem. Cytochem., February 1, 2005; 53(2): 237 - 242. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Medeiros, T. Khan, J. B. El Khoury, C. L. L. Pham, D. M. Hatters, G. J. Howlett, R. Lopez, K. D. O'Brien, and K. J. Moore Fibrillar Amyloid Protein Present in Atheroma Activates CD36 Signal Transduction J. Biol. Chem., March 12, 2004; 279(11): 10643 - 10648. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Andreola, V. Bellotti, S. Giorgetti, P. Mangione, L. Obici, M. Stoppini, J. Torres, E. Monzani, G. Merlini, and M. Sunde Conformational Switching and Fibrillogenesis in the Amyloidogenic Fragment of Apolipoprotein A-I J. Biol. Chem., January 17, 2003; 278(4): 2444 - 2451. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lotharius and P. Brundin Impaired dopamine storage resulting from {alpha}-synuclein mutations may contribute to the pathogenesis of Parkinson's disease Hum. Mol. Genet., October 1, 2002; 11(20): 2395 - 2407. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Hatters, A. P. Minton, and G. J. Howlett Macromolecular Crowding Accelerates Amyloid Formation by Human Apolipoprotein C-II J. Biol. Chem., March 1, 2002; 277(10): 7824 - 7830. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nishida, A. J Quantock, A. Dota, N.-H. Choi-Miura, and S. Kinoshita Apolipoproteins J and E co-localise with amyloid in gelatinous drop-like and lattice type I corneal dystrophies Br. J. Ophthalmol., October 1, 1999; 83(10): 1178 - 1182. [Abstract] [Full Text] |
||||
![]() |
A. A. Golabek, C. Soto, T. Vogel, and T. Wisniewski The Interaction between Apolipoprotein E and Alzheimer's Amyloid beta-Peptide Is Dependent on beta-Peptide Conformation J. Biol. Chem., May 3, 1996; 271(18): 10602 - 10606. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Hatters, R. A. Lindner, J. A. Carver, and G. J. Howlett The Molecular Chaperone, alpha -Crystallin, Inhibits Amyloid Formation by Apolipoprotein C-II J. Biol. Chem., August 31, 2001; 276(36): 33755 - 33761. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |